Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic Acid Injection in Mohs Surgery
NCT04630886Phase 1Terminated
- Start
- Jun 2021
- Primary completion
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of tranexamic acid in skin neoplasms (2 arms). Primary endpoint: Postoperative Complications at 12 weeks. Started Jun 2021; status: terminated.
02
Drugs
tranexamic acid
03
Conditions
skin neoplasms
Beyond the preview
Go deeper on NCT04630886.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04630886.